Ataxic gait and dysarthria in a child: pantothenate kinase-associated neurodegeneration as a diagnosis

被引:0
|
作者
Naggar, Amine [1 ,2 ]
Laasri, Khadija [1 ]
Fadil, Mohamed [1 ]
Allali, Nazik [1 ]
El Haddad, Siham [1 ]
Chat, Latifa [1 ]
机构
[1] Mohammed V Univ, Childrens Hosp Rabat, Radiol Dept, Rabat, Morocco
[2] Mohammed V Univ, Childrens Hosp Rabat, Mother Child Radiol Dept, Sale, Rabat, Morocco
来源
OXFORD MEDICAL CASE REPORTS | 2023年 / 2023卷 / 12期
关键词
pantothenate kinase-associated neurodegeneration; brain iron accumulation; globus pallidus; ataxia; MRI; THE-TIGER SIGN; EYE;
D O I
10.1093/omcr/omad134
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pantothenate kinase-associated neurodegeneration (or previously known as Hallervorden-Spatz syndrome) is a very rare disorder that typically manifests in a child with neurological signs such as gait difficulties, dysarthria, and hyperreflexia, associated potentially with psychiatric symptoms such as cognitive decline. It demonstrates on MRI the typical 'eye of the tiger' appearance, which is due to gliosis and accumulation of iron in the globi pallidi. Other differentials can mimic this appearance on MRI, it is therefore important to search for the involvement of other basal ganglia nuclei and the cerebral cortex, and also to consider the clinical and biological context.
引用
收藏
页码:456 / 457
页数:2
相关论文
共 50 条
  • [1] Amantadine for Gait Dysfunction in Pantothenate Kinase-Associated Neurodegeneration
    Al-Shorafat, Duha M.
    Lang, Anthony E.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2019, 46 (06) : 782 - 784
  • [2] Pantothenate Kinase-Associated Neurodegeneration
    Hartig, Monika B.
    Prokisch, Holger
    Meitinger, Thomas
    Klopstock, Thomas
    CURRENT DRUG TARGETS, 2012, 13 (09) : 1182 - 1189
  • [3] Pantothenate kinase-associated neurodegeneration is not a synucleinopathy
    Li, A.
    Paudel, R.
    Johnson, R.
    Courtney, R.
    Lees, A. J.
    Holton, J. L.
    Hardy, J.
    Revesz, T.
    Houlden, H.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2013, 39 (02) : 121 - 131
  • [4] Anticholinergic responsive freezing of gait as a presentation of pantothenate kinase-associated neurodegeneration
    Kuo, S. -H.
    Greene, P.
    MOVEMENT DISORDERS, 2010, 25 (07) : S502 - S502
  • [5] Anaesthesia recommendations for Pantothenate kinase-associated neurodegeneration
    Koc, Demet
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2020, 61
  • [6] Pantothenate kinase-associated neurodegeneration in Tunisian families
    Benrhouma, H.
    Kraoua, I.
    Klaa, H.
    Rouissi, A.
    Valente, E. M.
    Turki, I. Benyoussef
    MOVEMENT DISORDERS, 2019, 34 : S611 - S611
  • [7] Transcranial sonography in pantothenate kinase-associated neurodegeneration
    Vladimir S. Kostić
    Marina Svetel
    Milija Mijajlović
    Aleksandra Pavlović
    Milica Ječmenica-Lukić
    Dušan Kozić
    Journal of Neurology, 2012, 259 : 959 - 964
  • [8] Anticholinergic-responsive gait freezing in a patient with pantothenate kinase-associated neurodegeneration
    Prokisch, Holger
    Meitinger, Thomas
    Lee, Seung Yeob
    Kim, Do Hyoun
    Lee, Myung Sik
    MOVEMENT DISORDERS, 2008, 23 (02) : 283 - 284
  • [9] Multiple myeloma Pantothenate kinase-associated neurodegeneration
    Muenster, Tino
    Koc, Demet
    Bhattacharjee, Sulagna
    Stoeter, Peter
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2020, 61
  • [10] Redesigning therapies for pantothenate kinase-associated neurodegeneration
    Munshi, Muhammad I.
    Yao, Sarah J.
    Ben Mamoun, Choukri
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (03)